For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
13
views
0
references
 Top references
cited by
2
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      2,507
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Re: Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma.

      Author(s):
      Publication date (Electronic):
      Journal: The Journal of urology
      Publisher: Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): J. Urol.
          Title: The Journal of urology
          Publisher: Elsevier BV
          ISSN (Electronic): 1527-3792
          ISSN (Print): 0022-5347
          Publication date (Electronic): Dec 2012
          Volume: 188
          Issue: 6
          Article
          Publisher Item ID: S0022-5347(12)04789-1
          DOI: 10.1016/j.juro.2012.08.170
          PubMed ID: 23141221
          SO-VID: bcadce3b-6a7e-4b38-8f47-47a8d0662947
          History

          Data availability:

          Comments

          Comment on this article

          scite_

          Similar content2,507

          See all similar

          Cited by2

          See all cited by